Global Generic Injectables Market Size, Share, Forecast Report, 2020-2027

The global Generic Injectables market garnered revenue around USD XX Billion in 2019 and projected to reach USD XX Billion in 2027, with at a compound annual growth rate of 13.2% throughout the estimate period from 2020 to 2027.

Generic injectable is referred to as biologics that are used for the treatment of various disease and has same drug/ active ingredients as that of its respective branded versions. However, the inactive contents of the drugs can be varied. The increasing prevalence of chronic and infectious disease along with the advancement in research and academic initiatives by the private and governmental sector is expected to drive the market growth.

For instance, as per the World Health Organization (WHO) 2015, over 38 million death occur globally due to non- communicable chronic diseases annually, which is propelling demand for development of low-cost generic vaccines. Moreover, nearly 86% of infants are vaccinated the rest remain unvaccinated leading to a death toll of about 2-3 million infants annually. Shortage of branded sterile injectable has further led to the adoption of generic injectable which in-turn is expected to restrain the market growth.

This research report encompasses precise assessment of the market with the help of comprehensive qualitative insights and supportable prognoses regarding market size, consumption and production. The projections presented in the report have been derived using proven research methodologies and assumptions. It does so by means of comprehensive qualitative insights, historical statistics, and verifiable predictions about market revenue and sales.

The rapidly budding threat owed to the eruption of COVID-19 is impacting lives, communities, businesses, and industries across the globe. With businesses shuttered, flights grounded, COVID-19 is about to affect the global economy in different ways such as by directly upsetting production and demand, by generating supply chain disruption, and by its financial impact on firms and financial markets. Therefore, this report covers COVID-19 outbreak impact analysis on the Generic Injectables market under the research study. The market estimates offered in the report are the outcome of in-depth extensive secondary research, primary interviews and in-house professional assessments. These market evaluations have been measured by reviewing the impact of numerous social, political and economic factors coupled with recent market dynamics affecting the Generic Injectables market growth.

The global Generic Injectables market is characterized by the presence of numerous small as well as medium scale companies. These players are largely focused towards forward integration via raw material production, product manufacturing, and distribution across various industry verticals. The report recognizes numerous crucial manufacturers of the market. This research study aids to comprehend the strategies and associations that companies are converging to survive in this competitive marketplace. This report assists in understanding footprints of the manufacturers with the help of their global revenue, production, capacity and average selling price analysis for period 2016-2027.

Major manufacturers analysed under this study comprises:

• Novartis AG (Sandoz International GmbH)

• Baxter

• Fresenius SE & Co. KGaA

• Mylan N.V.

• Teva Pharmaceutical Industries Ltd.

• Hikma Pharmaceuticals plc

• Sanofi

• Biocon

• Reddy's Laboratories

• Aurobindo Pharma

• Zydus Cadila

• GlaxoSmithKline plc

• AstraZeneca plc.

This report delivers market breakdown and its revenue, consumption, production analysis and projections by categorizing it depending on parameters such as type, application/end-user, and region. This research report delivers the analysis and prognosis of revenue, production, price, market share and growth trend for different products such as:

Global Generic injectables Market, by Product type

• Monoclonal antibodies

• Cytokines

• Insulin

• Vaccines

• Others

Global Generic injectables Market, by Container

• Vials

• Ampoules

• Premix

• Prefilled syringes

Global Generic Injectables Market, by Application

• Oncology

• Anaesthesia

• Anti-infectives

• Parenteral nutrition

• Cardiovascular

• Others

Global Generic Injectables Market, by Distribution Channel

• Hospital pharmacy

• Retail pharmacy

• Drug stores

• Online prescription stores

• Others

Regional Analysis and Forecast

Further, this research study analyses market size, production, consumption and its advancement trends at global, regional, and country level for period 2016 to 2027 and covers following region in its scope:

• North America

 U.S.

 Canada

• Europe

 Germany

 U.K.

 Italy

 France

 Rest of EU

• Asia Pacific

 China

 India

 Japan

 Southeast Asia

 Rest of APAC

• Central & South America

 Brazil

 Argentina

 Rest of Central & South America

• Middle East and Africa


 Saudi Arabia

 Rest of MEA